Food And Beverages Industry Reports

Reports > Food And Beverages > Selected Report

Global Vaccine Adjuvants Market Report 2018

Single User: $2999
Multiple User: $3999
Enterprise User: $5999


Report Summary:

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Scope of the Report:
This report focuses on the Vaccine Adjuvants in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of vaccine adjuvants includes veterinary vaccine adjuvants and human vaccine adjuvants. And the proportion of human vaccine adjuvants in 2016 is about 52.4%. The veterinary vaccine adjuvants in 2015 are about 47.6%.
The classification of Veterinary Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 56.3%. The Subcutaneous in 2016 is about 29%.
The classification of Human Vaccine Adjuvants includes Oral, Subcutaneous, Intramuscular and Others. And the proportion of Intramuscular in 2016 is about 55.5%. The Subcutaneous in 2016 is about 28.8%.

The worldwide market for Vaccine Adjuvants is expected to grow at a CAGR of roughly 10.3% over the next five years, will reach 1010 million US$ in 2023, from 560 million US$ in 2017, according to a new GIR study.

Market Segment by Manufacturers, this report covers
SEPPIC
SDA BIO
Brenntag Biosector
SPI Pharma
MVP Laboratories
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Oral
Subcutaneous
Intramuscular
Others

Market Segment by Applications, can be divided into
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)

There are 15 Chapters to deeply display the global Vaccine Adjuvants market.
Chapter 1, to describe Vaccine Adjuvants Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Vaccine Adjuvants, with sales, revenue, and price of Vaccine Adjuvants, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Vaccine Adjuvants, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Vaccine Adjuvants sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents

1 Market Overview
1.1 Vaccine Adjuvants Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Subcutaneous
1.2.3 Intramuscular
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
1.3.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 SEPPIC
2.1.1 Business Overview
2.1.2 Vaccine Adjuvants Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 SDA BIO
2.2.1 Business Overview
2.2.2 Vaccine Adjuvants Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Brenntag Biosector
2.3.1 Business Overview
2.3.2 Vaccine Adjuvants Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 SPI Pharma
2.4.1 Business Overview
2.4.2 Vaccine Adjuvants Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 MVP Laboratories
2.5.1 Business Overview
2.5.2 Vaccine Adjuvants Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Tj Kaiwei
2.6.1 Business Overview
2.6.2 Vaccine Adjuvants Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novavax
2.7.1 Business Overview
2.7.2 Vaccine Adjuvants Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Zhuoyue
2.8.1 Business Overview
2.8.2 Vaccine Adjuvants Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aphios
2.9.1 Business Overview
2.9.2 Vaccine Adjuvants Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
2.10.1 Business Overview
2.10.2 Vaccine Adjuvants Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 CSL Limited
2.11.1 Business Overview
2.11.2 Vaccine Adjuvants Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Brenntag Biosector
2.12.1 Business Overview
2.12.2 Vaccine Adjuvants Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 SEPPIC
2.13.1 Business Overview
2.13.2 Vaccine Adjuvants Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SPI Pharma
2.14.1 Business Overview
2.14.2 Vaccine Adjuvants Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novavax
2.15.1 Business Overview
2.15.2 Vaccine Adjuvants Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Avanti Polar Lipids
2.16.1 Business Overview
2.16.2 Vaccine Adjuvants Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Aphios
2.17.1 Business Overview
2.17.2 Vaccine Adjuvants Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Vaccine Adjuvants Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Vaccine Adjuvants Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Vaccine Adjuvants Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine Adjuvants Manufacturer Market Share in 2017
3.3.2 Top 6 Vaccine Adjuvants Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Vaccine Adjuvants Market Analysis by Regions
4.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine Adjuvants Sales and Market Share by Regions (2013-2018)
4.1.2 Global Vaccine Adjuvants Revenue and Market Share by Regions (2013-2018)
4.2 North America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.3 Europe Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.5 South America Vaccine Adjuvants Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5 North America Vaccine Adjuvants by Countries
5.1 North America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
5.1.1 North America Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
5.1.2 North America Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
5.2 United States Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5.3 Canada Vaccine Adjuvants Sales and Growth Rate (2013-2018)
5.4 Mexico Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6 Europe Vaccine Adjuvants by Countries
6.1 Europe Vaccine Adjuvants Sales, Revenue and Market Share by Countries
6.1.1 Europe Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
6.2 Germany Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.3 UK Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.4 France Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.5 Russia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
6.6 Italy Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7 Asia-Pacific Vaccine Adjuvants by Countries
7.1 Asia-Pacific Vaccine Adjuvants Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
7.2 China Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.3 Japan Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.4 Korea Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.5 India Vaccine Adjuvants Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8 South America Vaccine Adjuvants by Countries
8.1 South America Vaccine Adjuvants Sales, Revenue and Market Share by Countries
8.1.1 South America Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
8.1.2 South America Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8.3 Argentina Vaccine Adjuvants Sales and Growth Rate (2013-2018)
8.4 Colombia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9 Middle East and Africa Vaccine Adjuvants by Countries
9.1 Middle East and Africa Vaccine Adjuvants Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Vaccine Adjuvants Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Vaccine Adjuvants Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.3 UAE Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.4 Egypt Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.5 Nigeria Vaccine Adjuvants Sales and Growth Rate (2013-2018)
9.6 South Africa Vaccine Adjuvants Sales and Growth Rate (2013-2018)
10 Global Vaccine Adjuvants Market Segment by Type
10.1 Global Vaccine Adjuvants Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Vaccine Adjuvants Sales and Market Share by Type (2013-2018)
10.1.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Subcutaneous Sales Growth and Price
10.3.1 Global Subcutaneous Sales Growth (2013-2018)
10.3.2 Global Subcutaneous Price (2013-2018)
10.4 Intramuscular Sales Growth and Price
10.4.1 Global Intramuscular Sales Growth (2013-2018)
10.4.2 Global Intramuscular Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Vaccine Adjuvants Market Segment by Application
11.1 Global Vaccine Adjuvants Sales Market Share by Application (2013-2018)
11.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2013-2018)
11.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications) Sales Growth (2013-2018)
12 Vaccine Adjuvants Market Forecast (2018-2023)
12.1 Global Vaccine Adjuvants Sales, Revenue and Growth Rate (2018-2023)
12.2 Vaccine Adjuvants Market Forecast by Regions (2018-2023)
12.2.1 North America Vaccine Adjuvants Market Forecast (2018-2023)
12.2.2 Europe Vaccine Adjuvants Market Forecast (2018-2023)
12.2.3 Asia-Pacific Vaccine Adjuvants Market Forecast (2018-2023)
12.2.4 South America Vaccine Adjuvants Market Forecast (2018-2023)
12.2.5 Middle East and Africa Vaccine Adjuvants Market Forecast (2018-2023)
12.3 Vaccine Adjuvants Market Forecast by Type (2018-2023)
12.3.1 Global Vaccine Adjuvants Sales Forecast by Type (2018-2023)
12.3.2 Global Vaccine Adjuvants Market Share Forecast by Type (2018-2023)
12.4 Vaccine Adjuvants Market Forecast by Application (2018-2023)
12.4.1 Global Vaccine Adjuvants Sales Forecast by Application (2018-2023)
12.4.2 Global Vaccine Adjuvants Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 40263

Category: 14

Published date: 2018-06-20 19:55:06

Number of Pages: 129

Publisher Name: GIR

Over all Rating: 91 % (Average of Ratings provided by clients)